Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Oct 24, 2024

BUY
$110.31 - $140.45 $937,083 - $1.19 Million
8,495 Added 64.26%
21,714 $2.46 Million
Q2 2024

Jul 22, 2024

BUY
$110.31 - $140.45 $109,758 - $139,747
995 Added 8.87%
12,214 $1.38 Million
Q1 2024

Oct 24, 2024

BUY
$114.22 - $140.1 $114,791 - $140,800
1,005 Added 8.23%
13,219 $1.83 Million
Q1 2024

Apr 19, 2024

BUY
$114.22 - $140.1 $68,189 - $83,639
597 Added 5.62%
11,219 $1.56 Million
Q4 2023

Jan 12, 2024

BUY
$75.49 - $124.16 $801,854 - $1.32 Million
10,622 New
10,622 $1.32 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $27.2B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Oak Harvest Investment Services Portfolio

Follow Oak Harvest Investment Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Harvest Investment Services, based on Form 13F filings with the SEC.

News

Stay updated on Oak Harvest Investment Services with notifications on news.